Melisi, D., Ishiyama, S., Sclabas, G. M., Fleming, J. B., Xia, Q., Tortora, G., . . . Chiao, P. J. (2008). LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.

Melisi, Davide, Satoshi Ishiyama, Guido M. Sclabas, Jason B. Fleming, Qianghua Xia, Giampaolo Tortora, James L. Abbruzzese, and Paul J. Chiao. LY2109761, a Novel Transforming Growth Factor β Receptor Type I and Type II Dual Inhibitor, As a Therapeutic Approach to Suppressing Pancreatic Cancer Metastasis. 2008.

Melisi, Davide, et al. LY2109761, a Novel Transforming Growth Factor β Receptor Type I and Type II Dual Inhibitor, As a Therapeutic Approach to Suppressing Pancreatic Cancer Metastasis. 2008.